Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804

Strong Performer, Getting Expensive

In 3 Starfolio Baskets

Download real time

1637.00 14.00 (0.86%)

Near 52W High of ₹1682.40

733.4K

NSE+BSE Volume

NSE 27 Aug, 2026 3:59 PM (IST)

US FDA Observation

Aurobindo Pharma's US subsidiary Lannett Company receives four observations from US FDA See details

Split history for Aurobindo Pharma

Aurobindo Pharma has split the face value 2 times since Oct. 23, 2003. Aurobindo Pharma had last split the face value of its shares from ₹5 to ₹1 in 2011.The share has been quoting on an ex-split basis from Feb. 10, 2011.

Ex-Date	Old FV	New FV	Record Date
10 Feb 2011	5	1	11 Feb 2011
23 Oct 2003	10	5	31 Oct 2003

See all forthcoming Bonus and split

Is Aurobindo Pharma Ltd. worth buying?

1268 Votes:

Buy 80.36%

Sell 13.64%

Hold 5.99%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Buy SEE REPORTS >